IRIDEX Corporation

5.50+0.1000+1.85%Vol 4.22K1Y Perf -0.55%
Jan 20th, 2022 11:08 DELAYED
BID5.32 ASK5.53
Open5.30 Previous Close5.40
Pre-Market- After-Market-
 - -%  - -
Target Price
10.25 
Analyst Rating
Strong Buy 1.00
Potential %
88.07 
Finscreener Ranking
★★★★+     56.41
Insiders Trans % 3/6/12 mo.
100/100/100 
Value Ranking
★★★     50.64
Insiders Value % 3/6/12 mo.
100/100/100 
Growth Ranking
★★+     49.42
Insiders Shares Cnt. % 3/6/12 mo.
100/100/100 
Income Ranking
 —    -
Price Range Ratio 52W %
19.96 
Earnings Rating
Strong Sell
Market Cap87.08M 
Earnings Date
11th Nov 2021
Alpha-0.01 Standard Deviation0.19
Beta1.17 

Today's Price Range

5.305.50

52W Range

4.459.71

5 Year PE Ratio Range

-6.50456.50

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-8.78%
1 Month
-4.59%
3 Months
-31.39%
6 Months
-18.55%
1 Year
-0.55%
3 Years
12.73%
5 Years
-59.82%
10 Years
43.62%

TickerPriceChg.Chg.%
IRIX5.500.10001.85
AAPL169.062.83001.70
GOOG2 749.5136.47001.34
MSFT310.757.42002.45
XOM73.790.68000.93
WFC56.070.50000.90
JNJ167.711.13000.68
FB325.255.66001.77
GE101.440.82000.81
JPM149.991.06000.71
Financial StrengthValueIndustryS&P 500US Markets
2.60
3.40
0.07
0.11
-
Leverage Ratio 1.90
ProfitabilityValueIndustryS&P 500US Markets
44.00
-10.70
-9.30
-23.20
-7.20
RevenueValueIndustryS&P 500US Markets
38.65M
2.44
5.13
-3.74
Earnings HistoryEstimateReportedSurprise %
Q03 2021-0.15-0.146.67
Q02 2021-0.16-0.0943.75
Q01 2021-0.14-0.140.00
Q04 2020-0.11-0.0190.91
Q03 2020-0.18-0.1233.33
Q02 2020-0.23-0.2013.04
Q01 2020-0.17-0.1229.41
Q04 2019-0.16-0.1131.25
Earnings Per EndEstimateRevision %Trend
12/2021 QR-0.11-22.22Negative
12/2021 FY-0.30-7.14Negative
3/2022 QR-0.11-10.00Negative
12/2022 FY-0.30-30.43Negative
Next Report Date-
Estimated EPS Next Report-0.14
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume4.22K
Shares Outstanding15.83M
Shares Float14.11M
Trades Count35
Dollar Volume23.76K
Avg. Volume32.49K
Avg. Weekly Volume35.78K
Avg. Monthly Volume29.54K
Avg. Quarterly Volume52.72K

IRIDEX Corporation (NASDAQ: IRIX) stock closed at 5.4 per share at the end of the most recent trading day (a -1.28% change compared to the prior day closing price) with a volume of 23.03K shares and market capitalization of 87.08M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 132 people. IRIDEX Corporation CEO is David I. Bruce.

The one-year performance of IRIDEX Corporation stock is -0.55%, while year-to-date (YTD) performance is -11.62%. IRIX stock has a five-year performance of -59.82%. Its 52-week range is between 4.45 and 9.71, which gives IRIX stock a 52-week price range ratio of 19.96%

IRIDEX Corporation currently has a PE ratio of -26.60, a price-to-book (PB) ratio of 3.50, a price-to-sale (PS) ratio of 2.29, a price to cashflow ratio of 8.50, a PEG ratio of 2.32, a ROA of -7.50%, a ROC of -11.85% and a ROE of -13.91%. The company’s profit margin is -7.20%, its EBITDA margin is -9.30%, and its revenue ttm is $38.65 Million , which makes it $2.44 revenue per share.

Of the last four earnings reports from IRIDEX Corporation, there were 3 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.14 for the next earnings report. IRIDEX Corporation’s next earnings report date is -.

The consensus rating of Wall Street analysts for IRIDEX Corporation is Strong Buy (1), with a target price of $10.25, which is +88.07% compared to the current price. The earnings rating for IRIDEX Corporation stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

IRIDEX Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

IRIDEX Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 47.58, ATR14 : 0.39, CCI20 : -125.96, Chaikin Money Flow : -0.20, MACD : -0.23, Money Flow Index : 25.70, ROC : -11.62, RSI : 38.85, STOCH (14,3) : 8.47, STOCH RSI : 0.17, UO : 36.84, Williams %R : -91.53), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of IRIDEX Corporation in the last 12-months were: Nandini Devi (Buy at a value of $7 730)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing and marketing laser-based medical systems, delivery devices and consumable instrumentation for ophthalmology. Its products include lasers, laser delivery devices, glaucoma devices, retinal surgical instruments, veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment that is ophthalmology. The geographical segments of the company include the United States, Europe, the Americas, excluding the U.S and Asia/Pacific.

CEO: David I. Bruce

Telephone: +1 650 940-4700

Address: 1212 Terra Bella Avenue, Mountain View 94043, CA, US

Number of employees: 132

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

49%51%

Bearish Bullish

43%57%

News

Stocktwits